Together, these data confirm that CD37 mRNA is translated and expressed at the surface of AML cells, but its detection efficiency might only be restricted to some antibodies, thus making CD37 a potential HH1 antibody-based CAR target. Here, CD37 is linked to acute myeloid leukemia.